"Nature" announced the top ten figures in 2024, and two China scientists were selected. On the 9th, the website of the British magazine "Nature" released the list of the top ten figures promoting scientific development in 2024. Among them, two China scientists were selected. The list was compiled by the editors of Nature magazine to record the important scientific progress, events and some key figures this year. Among them, two China researchers who were selected as the top ten were Xu Huji, a rheumatologist from the PLA Naval Medical University, and Li Chunlai, deputy chief designer of the Chang 'e VI mission and a researcher at the National Astronomical Observatory of the Chinese Academy of Sciences. Dr. Xu Huji bravely tried to treat autoimmune diseases with CAR-T cell therapy, which brought hope for the mass production of CAR-T cell therapy. Li Chunlai was a key figure in determining the landing site of Chang 'e-6 probe on the moon, and was also one of the first scientists to analyze the returned samples.The contracted sales of Xuhui Holding Group in November was 2.27 billion yuan, a year-on-year decrease of 41%.Sources: Boeing restarted the production of 737 MAX last week. Sources said that about one month after the strike ended, Boeing restarted the production of 737 MAX aircraft last week.
Tang Hui, former member of the Standing Committee of Anshun Municipal Committee of Guizhou Province, was "double-opened", and the website of the State Supervision Committee of the Central Commission for Discipline Inspection was notified on December 10. According to the news of the Supervision Committee of Guizhou Provincial Commission for Discipline Inspection, with the approval of Guizhou Provincial Committee, the Supervision Committee of Guizhou Provincial Commission for Discipline Inspection filed a case review and investigation on Tang Hui, former member of the Standing Committee of Anshun Municipal Committee of Guizhou Province and former secretary of Xixiu District Committee.Australia's S&P/ASX200 index has narrowed its decline and is now down 0.3%.Minister of Malaysia: ZTE will invest 200 million ringgit in Malaysia.
Reserve Bank of Australia: It will take some time for inflation to continue to reach its target. The job market is still tight. The economic situation has affected the family's discretionary expenditure. The gap between total demand and supply continues to narrow, and output growth is weak.Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
Strategy guide
12-13